SPP1 and Alzheimer disease: To be specific, in the urine of AD patients, secreted phosphoprotein 1 (SPP1) was downregulated, whereas gelsolin (GSN) and insulin-like growth factor-binding protein-7 (IGFBP7) were upregulated, which made them promising biomarkers for AD.